Secondary Logo

Journal Logo

The Use of Continuous Glucose Monitoring System in the Home Health Setting

Home Healthcare Nurse: The Journal for the Home Care and Hospice Professional: May 2010 - Volume 28 - Issue 5 - p 295–297
doi: 10.1097/01.NHH.0000374867.90769.44
CE Connection
Back to Top | Article Outline

The Use of Continuous Glucose Monitoring System (CGM) in the Home Health Setting


  • To take the test online, go to our secure Web site at
  • On the print form, record your answers in the test answer section of the CE enrollment form on page 297. Each question has only one correct answer. You may make copies of these forms.
  • Complete the registration information and course evaluation. Mail the completed form and registration fee of $17.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
  • You will receive your CE certificate of earned contact hours and an answer key to review your results. There is no mini- mum passing grade.
  • Registration deadline is May 31, 2012.
Back to Top | Article Outline


  • Send two or more tests in any nursing journal published by Lippincott, Williams & Wilkins together and deduct $0.95 from the price of each test.
  • We also offer CE accounts for hospitals and other health care facilities on Call 1-800-787-8985 for details.
Back to Top | Article Outline


Lippincott Williams & Wilkins, publisher of Home Healthcare Nurse, will award 1.9 contact hours for this continuing nursing education activity.

Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 1.9 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454. Your certificate is valid in all states.

The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.

Back to Top | Article Outline



To present registered professional nurses with a case study illustrating the benefits of and barriers to using a continuous glucose monitoring system.

Back to Top | Article Outline


After reading this article and taking this test, you should be able to:

  • Outline the prevalence, classifications, and costs associated with diabetes mellitus.
  • Summarize the monitoring guidelines for diabetes mellitus.
  • Plan the appropriate interventions for patients with diabetes mellitus who are using a continuous glucose monitoring system.

1. Of all cases of diabetes mellitus, about what percentage is classified as type 1?

a. 5% to 10%

b. 10% to 15%

c. 15% to 20%

d. 20% to 25%

2. Of all cases of diabetes mellitus, about what percentage is classified as type 2?

a. 75% to 80%

b. 80% to 85%

c. 85% to 90%

d. 90% to 95%

3. According to the Centers for Disease Control and Prevention, (CDC), diabetes and its complications cost the United States how much in direct and indirect costs in 2007?

a. $94 billion

b. $134 billion

c. $174 billion

d. $214 billion

4. How many people in the United States have diabetes mellitus?

a. 12 million

b. 16 million

c. 20 million

d. 24 million

5. According to the CDC, the number of people who have diabetes is likely to double by the year

a. 2040.

b. 2050.

c. 2060.

d. 2070.

6. According to the CDC, a person who has diabetes spends about how much more per year on health care than a person who does not have diabetes spends?

a. $4,500

b. $5,400

c. $6,600

d. $7,300

7. Glycated hemoglobin (A1C) provides an estimate of a person's average blood glucose level for the past

a. week.

b. month.

c. two months.

d. three months.

8. For patients who are not having recurrent hypoglycemia, the ADA recommends an A1C of

a. at least 6%.

b. no more than 7%.

c. no less than 8%.

d. about 9%.

9. An A1C of which of the following correlates with a mean plasma glucose of 126 mg/dL?

a. 6%

b. 7%

c. 8%

d. 9%

10. An A1C of 11% correlates with a mean plasma glucose of

a. 212 mg/dL.

b. 240 mg/dL.

c. 269 mg/dL.

d. 298 mg/dL.

11. For continuous glucose monitoring (CGM), current technology allows wireless sensors to stay in place from

a. 1 to 3 days.

b. 3 to 7 days.

c. 7 to 10 days.

d. 10 to 14 days.

12. With CGM, how many times per day are patients required to calibrate by comparing capillary self-monitoring of blood glucose (SMBG) via fingerstick with interstitial CGM?

a. one

b. two

c. three

d. four

13. Of the following, which is the ideal time to perform fingerstick SMBG for calibration purposes?

a. during a meal

b. 1 hour after a meal

c. 2 hours after a meal

d. 3 hours after a meal

14. While the CGM sensor is in place, glucose levels are measured every

a. 1 to 10 minutes.

b. 11 to 20 minutes.

c. 21 to 30 minutes.

d. 31 to 40 minutes.

15. Which of the following is a requirement for patients who use CGM?

a. regular insulin use

b. acceptable A1C percentages

c. venous access

d. technological ability



© 2010 Lippincott Williams & Wilkins, Inc.